NIH-funded research NIH-funded research

Understanding how to better treat chronic coughing in patients with cough hypersensitivity syndrome.

Official title: Identifying Predictors of Treatment Response to Pharmacologic and Nonpharmacologic Interventions in Cough Hypersensitivity Syndrome

Funded at Univ of North Carolina Chapel Hill · NIH-10985323 · Data updated 2026-11-12

This study is looking at ways to help people with cough hypersensitivity syndrome (CHS) by figuring out which treatments, like medications or therapy, work best for different individuals, so you can get the right help without the guesswork.

More Cough research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startAugust 15, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$142,804
NIH project number1K23HL169934-01A1
Project IDNIH-10985323 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who experience chronic coughing associated with cough hypersensitivity syndrome.

Less likely to help

Patients with chronic cough not related to cough hypersensitivity syndrome may not benefit from this research.

What this research studies

This research investigates cough hypersensitivity syndrome (CHS), a condition marked by chronic coughing that can lead to serious health issues. The study aims to identify predictors of treatment response to both pharmacologic options, like medications and nerve blocks, and nonpharmacologic approaches, such as cognitive behavioral therapy through speech therapy. By analyzing cough symptoms, the research seeks to categorize patients into subgroups that will help determine the most effective treatment for each individual, moving away from a trial-and-error approach. This could lead to more personalized and effective treatment strategies for those suffering from CHS.

Why it matters

Potential benefit: If successful, this research could lead to more effective and tailored treatments for patients suffering from chronic coughing due to cough hypersensitivity syndrome.

How similar studies have gone: Preliminary work has shown promise in identifying cough symptomology as a predictor for treatment response, indicating potential success in this area of research.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Novaleski, Carolyn K. — Univ of North Carolina Chapel Hill
  • Study coordinator: Novaleski, Carolyn K.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.